UK collaboration to manufacture commercial viral vectors
Cobra Biologics and Symbiosis have received a grant to establish a commercial viral vector manufacturing facility in the UK.
Archives for February 9, 2018
Cook in the books: Biologics acquisition boosts Catalent Q2
Catalent has partially attributed a 26% year-on-year growth in its Drug Delivery Solutions segment to the acquisition of Cook Pharmica, which closed in the quarter.
Cryoport wins TiGenix logistics contract and braces for CAR T roll out
Cryoport will provide cold chain logistics to TiGenix as it conducts phase Ib/IIa allogeneic adipose‐derived stem cells for the treatment of sepsis.
Operations reshuffle behind job cuts at Sanofi Genzyme
Outsourcing and operational changes at the Allston Landing facility influenced Sanofi’s decision to layoff workers in Massachusetts, US.